An adaptive‐design dose‐ranging study of PD 0348292, an oral factor Xa inhibitor, for thromboprophylaxis after total knee replacement surgery

201321 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Thrombosis and Haemostasis

Volume 11, Issue 8, pp. 1503-1510

Field-Weighted Citation Impact: 0.95